Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4572691017 | Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4572692012 | Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 1134241000001116 | Lidocaine 5% / Phenylephrine 0.5% nasal spray | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has basis of strength substance | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has basis of strength substance | Phenylephrine hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Is a | Product containing only lidocaine and phenylephrine in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has precise active ingredient | Phenylephrine hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has manufactured dose form | Conventional release cutaneous spray | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Is a | Lidocaine + Phenylephrine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutionspray.nasal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has specific active ingredient | Phenylephrine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has dispensed dose form | Spray dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Nasal route | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lidocaine 5% / Phenylephrine 0.5% nasal spray 2.5 ml | Has VMP | True | Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lidocaine 5% / Phenylephrine 0.5% nasal spray (Martindale Pharmaceuticals Ltd) | Is a | True | Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lidocaine 5% / Phenylephrine 0.5% nasal spray (Unichem Plc) | Is a | True | Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lidocaine 5% / Phenylephrine 0.5% nasal spray (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Lidocaine 5% / Phenylephrine 0.5% nasal spray (Ennogen Healthcare Ltd) | Is a | True | Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release cutaneous spray (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR